Last reviewed · How we verify

Local anesthesia at incision site

The University of Texas Health Science Center, Houston · FDA-approved active Small molecule Quality 5/100

Local anesthesia at incision site is a Small molecule drug developed by The University of Texas Health Science Center, Houston. It is currently FDA-approved.

At a glance

Generic nameLocal anesthesia at incision site
SponsorThe University of Texas Health Science Center, Houston
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Local anesthesia at incision site

What is Local anesthesia at incision site?

Local anesthesia at incision site is a Small molecule drug developed by The University of Texas Health Science Center, Houston.

Who makes Local anesthesia at incision site?

Local anesthesia at incision site is developed and marketed by The University of Texas Health Science Center, Houston (see full The University of Texas Health Science Center, Houston pipeline at /company/the-university-of-texas-health-science-center-houston).

What development phase is Local anesthesia at incision site in?

Local anesthesia at incision site is FDA-approved (marketed).

Related